An advanced understanding of the heterogeneous clinical features of “non-criteria” obstetric antiphospholipid syndrome: Two case reports and a literature review
Frontiers in Immunology · 2023
DOI: 10.3389/fimmu.2023.1122127 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, 2023. Verfasst von Xue Peng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Premature Birth, Autoimmune Diseases, Abortion, Habitual. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Sichuan Province Science and Technology Support Program.
Abstract (Originalsprache)
Antiphospholipid syndrome (APS) is an acquired autoimmune disorder characterized by recurrent venous and/or arterial thrombosis and/or pregnancy complications, in the presence of elevated antiphospholipid (aPL) antibodies. APS in pregnant women is referred to as “obstetrical” APS (OAPS). The diagnosis of definite OAPS requires the presence of one or more typical clinical criteria and persistent aPL antibodies at least 12 weeks apart. However, the classification criteria for OAPS have generated wide discussion, with a growing impression that certain patients not fully meeting these criteria might be inappropriately excluded from the classification, which is known as “non-criteria” OAPS. We present here two unique cases of potentially lethal “non-criteria” OAPS, complicating severe preeclampsia, fetal growth restriction (FGR), liver rupture, preterm birth, refractory recurrent miscarriages, or even stillbirth. We further share our diagnostic search and analysis, treatment adjustment, and prognosis for this unusual antenatal event. We will also present a short review of an advanced understanding of the pathogenetic mechanisms of this disease, heterogeneous clinical features, and potential significance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
Förderung
- National Key Research and Development Program of China
- Sichuan Province Science and Technology Support Program
Zitieren
APA
Peng, X., Tan, X., & Xing, A. (2023). An advanced understanding of the heterogeneous clinical features of “non-criteria” obstetric antiphospholipid syndrome: Two case reports and a literature review. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1122127
Vancouver
Peng X, Tan X, Xing A. An advanced understanding of the heterogeneous clinical features of “non-criteria” obstetric antiphospholipid syndrome: Two case reports and a literature review. Frontiers in Immunology. 2023. doi:10.3389/fimmu.2023.1122127
BibTeX
@article{Peng2023,
author = {Peng, Xue and Tan, Xi and Xing, Aiyun},
title = {An advanced understanding of the heterogeneous clinical features of “non-criteria” obstetric antiphospholipid syndrome: Two case reports and a literature review},
journal = {Frontiers in Immunology},
year = {2023},
doi = {10.3389/fimmu.2023.1122127}
}
EUVIMED